D'INCALCI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 595
EU - Europa 79
AS - Asia 71
Totale 745
Nazione #
US - Stati Uniti d'America 595
IT - Italia 48
CN - Cina 40
SG - Singapore 29
SE - Svezia 11
FR - Francia 6
FI - Finlandia 5
GB - Regno Unito 4
DE - Germania 3
IN - India 2
NL - Olanda 1
RU - Federazione Russa 1
Totale 745
Città #
Fairfield 115
Chandler 57
Woodbridge 57
Houston 46
Seattle 46
Ashburn 42
Cambridge 39
Centrale 32
Wilmington 32
Singapore 23
Santa Clara 22
Ann Arbor 21
San Diego 11
Boardman 9
Beijing 8
Medford 8
Princeton 8
Padova 6
Des Moines 5
Guangzhou 4
Falls Church 3
London 3
Nanjing 3
New York 3
Changsha 2
Helsinki 2
Nanchang 2
Shanghai 2
Zhengzhou 2
Amsterdam 1
Dallas 1
Fuzhou 1
Haikou 1
Hebei 1
Hefei 1
Jiaxing 1
Jinan 1
Mumbai 1
Ningbo 1
Ogden 1
Rovereto 1
Southwark 1
Taizhou 1
Tianjin 1
Tyumen 1
Totale 629
Nome #
lncRNAs as novel indicators of patients' prognosis in stage I epithelial ovarian cancer: a retrospective and multicentric study 135
Reduced expression of the rock inhibitor rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells 107
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 102
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 97
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia 87
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study 86
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour 72
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 68
Totale 754
Categoria #
all - tutte 3.043
article - articoli 3.043
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 0 0 0 0 14 23 31 13 12 9
2020/202191 5 13 9 5 11 1 1 6 20 5 13 2
2021/2022134 5 19 13 5 6 15 7 15 5 5 11 28
2022/202397 15 16 8 4 18 8 0 9 16 1 2 0
2023/202445 0 7 7 3 3 3 2 3 2 5 4 6
2024/202583 5 25 9 6 31 7 0 0 0 0 0 0
Totale 754